2H-PHTHALAZIN-1-ONE DERIVATIVES AND DRUGS COMPRISING THESE DERIVATIVES AS THE ACTIVE INGREDIENT
申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP1148053A1
公开(公告)日:2001-10-24
Poly(ADP-ribose)polymerase inhibitors containing as the active ingredient 2H-phthalazin-1-one derivatives represented by general formula (I) (wherein each symbol is as defined in the description) or salts thereof.
The compounds of the general formula (I) inhibit poly(ADP-ribose)polymerase and are useful as preventives and/or remedies for various ischemic diseases (brain, heart, digestive tract, skeletal muscle, retina, etc.), inflammatory diseases (inflammatory intestinal diseases, multiple encephalosclerosis, arthritis, etc.), nerve degeneration diseases (extrapyramidal disorder, Alzheimer's disease, muscular dystrophy, etc.), diabetes, shock, head trauma, renal insufficiency, hyperalgesia, etc. These compounds are also useful as sensitizers for agents against retroviruses (HIV, etc.) and chemotherapy for cancer.
聚(ADP-核糖)聚合酶抑制剂,其活性成分为通式(I)代表的 2H-酞嗪-1-酮衍生物(其中各符号如描述中所定义)或其盐。
通式(I)化合物可抑制聚(ADP-核糖)聚合酶,可用于预防和/或治疗各种缺血性疾病(脑、心脏、消化道、骨骼肌、视网膜等)、炎症性疾病(炎症性心肌梗塞、心肌梗死、心律失常、心肌梗死等)。这些化合物可用于预防和/或治疗各种缺血性疾病(脑部、心脏、消化道、骨骼肌、视网膜等)、炎症性疾病(肠道炎症性疾病、多发性脑硬化症、关节炎等)、神经变性疾病(锥体外系障碍、老年痴呆症、肌肉萎缩症等)、糖尿病、休克、头部外伤、肾功能不全、痛觉减退等。这些化合物还可用作抗逆转录病毒(HIV 等)药物和癌症化疗的增敏剂。